Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2019 · 10-Q
Revenue—
Net Income-$3.05M-$3.05MN/M vs Q1 2018 EPS Diluted-$0.27-$0.27N/M vs Q1 2018 Operating Income-$3,083,071N/M Operating Cash Flow-$3,308,484N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end